Testing effectiveness (Phase 2)Study completedNCT00129259
What this trial is testing
Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID) 83